Cargando…
Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development
Dementia is reported to be common in those with type 2 diabetes mellitus. Type 2 diabetes contributes to common molecular mechanisms and an underlying pathology with dementia. Brain cells becoming resistant to insulin leads to elevated blood glucose levels, impaired synaptic plasticity, microglial o...
Autores principales: | Singh, Desh Deepak, Shati, Ali A., Alfaifi, Mohammad Y., Elbehairi, Serag Eldin I., Han, Ihn, Choi, Eun-Ha, Yadav, Dharmendra K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738282/ https://www.ncbi.nlm.nih.gov/pubmed/36497027 http://dx.doi.org/10.3390/cells11233767 |
Ejemplares similares
-
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
por: Singh, Desh Deepak, et al.
Publicado: (2020) -
A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors
por: Singh, Desh Deepak, et al.
Publicado: (2023) -
Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2
por: Singh, Desh Deepak, et al.
Publicado: (2020) -
CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer
por: Deepak Singh, Desh, et al.
Publicado: (2021) -
Flavonol Glycosides: In Vitro Inhibition of DPPIV, Aldose Reductase and Combating Oxidative Stress are Potential Mechanisms for Mediating the Antidiabetic Activity of Cleome droserifolia
por: Abdel Motaal, Amira, et al.
Publicado: (2020)